» Articles » PMID: 12000757

Dependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 May 10
PMID 12000757
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

The agonist-induced androgen receptor NH(2)- and COOH-terminal (N/C) interaction is mediated by the FXXLF and WXXLF NH(2)-terminal motifs. Here we demonstrate that agonist-dependent transactivation of prostate-specific antigen (PSA) and probasin enhancer/promoter regions requires the N/C interaction, whereas the sex-limited protein gene and mouse mammary tumor virus long terminal repeat do not. Transactivation of PSA and probasin response regions also depends on activation function 1 (AF1) in the NH(2)-terminal region but can be increased by binding an overexpressed p160 coactivator to activation function 2 (AF2) in the ligand binding domain. The dependence of the PSA and probasin enhancer/promoters on the N/C interaction for transactivation allowed us to demonstrate that in the presence of androgen, the WXXLF motif with the sequence (433)WHTLF(437) contributes as an inhibitor to AR transactivation. We further show that like the FXXLF and LXXLL motifs, the WXXLF motif interacts in the presence of androgen with AF2 in the ligand binding domain. Sequence comparisons among species indicate greater conservation of the FXXLF motif compared with the WXXLF motif, paralleling the functional significance of these binding motifs. The data provide evidence for promoter-specific differences in the requirement for the androgen receptor N/C interaction and in the contributions of AF1 and AF2 in androgen-induced gene regulation.

Citing Articles

Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells.

Safi R, Wardell S, Watkinson P, Qin X, Lee M, Park S Nat Commun. 2024; 15(1):7675.

PMID: 39227594 PMC: 11371910. DOI: 10.1038/s41467-024-52032-y.


Intracrine androgen biosynthesis and drug resistance.

Penning T, Asangani I, Sprenger C, Plymate S Cancer Drug Resist. 2022; 3(4):912-929.

PMID: 35582223 PMC: 8992556. DOI: 10.20517/cdr.2020.60.


Steroid receptor-coregulator transcriptional complexes: new insights from CryoEM.

Yi P, Yu X, Wang Z, OMalley B Essays Biochem. 2021; 65(6):857-866.

PMID: 34061186 PMC: 8845409. DOI: 10.1042/EBC20210019.


Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes.

Yu X, Yi P, Hamilton R, Shen H, Chen M, Foulds C Mol Cell. 2020; 79(5):812-823.e4.

PMID: 32668201 PMC: 7483370. DOI: 10.1016/j.molcel.2020.06.031.


Androgen Receptor Dependence.

Chaturvedi A, Dehm S Adv Exp Med Biol. 2020; 1210:333-350.

PMID: 31900916 PMC: 8990348. DOI: 10.1007/978-3-030-32656-2_15.